Simian-Human Immunodeficiency Virus SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques Is Characterized by Elevated SHIV RNA in the Gut and a High Abundance of Intact SHIV DNA in Naive CD4


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
22 12 2020
Historique:
received: 21 08 2020
accepted: 14 10 2020
pubmed: 23 10 2020
medline: 17 3 2021
entrez: 22 10 2020
Statut: epublish

Résumé

Mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) continues to cause new pediatric cases of infection through breastfeeding, a setting where it is not always possible to initiate early antiretroviral therapy (ART). Without novel interventions that do not rely on daily ART, HIV-1-infected children face lifelong medications to control infection. A detailed analysis of virus persistence following breast milk transmission of HIV-1 and ART has not been performed. Here, we used infant rhesus macaques orally infected with simian/human immunodeficiency virus (SHIV) (SHIV.C.CH505) to identify cellular and anatomical sites of virus persistence under ART. Viral DNA was detected at similar levels in blood and tissue CD4

Identifiants

pubmed: 33087463
pii: JVI.01669-20
doi: 10.1128/JVI.01669-20
pmc: PMC7944446
pii:
doi:

Substances chimiques

Anti-Retroviral Agents 0
DNA, Viral 0
RNA, Viral 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : T32 AI007392
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI050409
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI131306
Pays : United States
Organisme : NIH HHS
ID : P51 OD011132
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA138292
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI131251
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI118549
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI131276
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI131331
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI074492
Pays : United States

Informations de copyright

Copyright © 2020 Obregon-Perko et al.

Références

Nat Rev Immunol. 2016 Apr;16(4):259-71
pubmed: 26972723
J Infect Dis. 1999 Dec;180(6):1838-43
pubmed: 10558939
AIDS. 2004 Dec 3;18(18):2371-80
pubmed: 15622313
Nat Med. 1999 May;5(5):512-7
pubmed: 10229227
J Virol. 2018 Jun 13;92(13):
pubmed: 29643246
J Virol. 2020 Jan 31;94(4):
pubmed: 31776265
Proc Natl Acad Sci U S A. 2017 May 2;114(18):E3659-E3668
pubmed: 28416661
mBio. 2019 Sep 5;10(5):
pubmed: 31488511
Cell Host Microbe. 2019 Jul 10;26(1):73-85.e4
pubmed: 31295427
J Virol. 2014 Dec;88(24):14070-7
pubmed: 25253353
Cell Rep. 2017 Oct 17;21(3):813-822
pubmed: 29045846
Nat Med. 2016 Jul;22(7):754-61
pubmed: 27239760
Nat Med. 2016 Apr;22(4):362-8
pubmed: 26998834
Immunity. 2016 Sep 20;45(3):656-668
pubmed: 27653601
Nature. 2017 Nov 22;551(7681):E6-E9
pubmed: 29168805
Clin Infect Dis. 2019 Nov 13;69(11):1919-1925
pubmed: 30753360
PLoS Pathog. 2018 Nov 15;14(11):e1007357
pubmed: 30440043
J Infect Dis. 2013 Oct 15;208(8):1212-20
pubmed: 23852128
AIDS Res Hum Retroviruses. 2018 Jan;34(1):123-125
pubmed: 29084441
Science. 2001 Apr 6;292(5514):69-74
pubmed: 11393868
BMC Pediatr. 2010 May 18;10:33
pubmed: 20482796
Sci Transl Med. 2020 Mar 4;12(533):
pubmed: 32132218
J Virol. 2019 Dec 12;94(1):
pubmed: 31597776
Blood. 2012 Nov 15;120(20):4172-81
pubmed: 22990012
ILAR J. 2017 Dec 1;58(2):160-171
pubmed: 29228218
AIDS Res Hum Retroviruses. 2018 Mar;34(3):286-299
pubmed: 29237287
Curr Opin HIV AIDS. 2016 Jul;11(4):432-41
pubmed: 27152962
BMC Infect Dis. 2016 Dec 7;16(1):738
pubmed: 27927183
J Virol. 2018 Aug 29;92(18):
pubmed: 29997216
Blood. 2012 Nov 22;120(22):4383-90
pubmed: 23033270
Front Immunol. 2018 Jul 30;9:1759
pubmed: 30105028
Nat Med. 2009 Aug;15(8):893-900
pubmed: 19543283
Immunity. 2003 Mar;18(3):441-52
pubmed: 12648460
J Exp Med. 2013 Jan 14;210(1):143-56
pubmed: 23254284
Science. 1997 Nov 14;278(5341):1295-300
pubmed: 9360927
J Infect Dis. 2002 Aug 1;186(3):312-20
pubmed: 12134227
J Virol. 2006 Jul;80(13):6357-67
pubmed: 16775324
J Virol. 2016 Aug 26;90(18):8059-73
pubmed: 27356901
Nat Med. 2017 Nov;23(11):1271-1276
pubmed: 28967921
J Virol. 2020 Oct 14;94(21):
pubmed: 32817214
Adv Pharmacol. 2000;49:437-77
pubmed: 11013771
JCI Insight. 2020 Feb 27;5(4):
pubmed: 31999647
Nature. 2020 Feb;578(7793):160-165
pubmed: 31969707
Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2307-12
pubmed: 24469825
J Infect Dis. 2017 Mar 15;215(suppl_3):S142-S151
pubmed: 28520967
J Infect Dis. 2010 Nov 15;202(10):1553-61
pubmed: 20939732
Lancet. 2000 Apr 1;355(9210):1131-7
pubmed: 10791375
Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3704-3710
pubmed: 32029589
Sci Transl Med. 2020 Jan 29;12(528):
pubmed: 31996465
Clin Pharmacokinet. 2015 Jun;54(6):581-98
pubmed: 25777740
J Virol. 2015 Nov 18;90(3):1369-76
pubmed: 26581989
Science. 2014 Jul 11;345(6193):179-83
pubmed: 24968937
Curr HIV/AIDS Rep. 2020 Jun;17(3):237-248
pubmed: 32356090
J Virol. 2007 Aug;81(16):8827-32
pubmed: 17537848
Proc Natl Acad Sci U S A. 2016 Jun 14;113(24):E3413-22
pubmed: 27247400
Mucosal Immunol. 2020 Jan;13(1):149-160
pubmed: 31723251
J Infect Dis. 2014 Nov 15;210(10):1529-38
pubmed: 24850788
Science. 2000 Oct 20;290(5491):486-92
pubmed: 11039923
Nature. 2019 Feb;566(7742):120-125
pubmed: 30700913
Sci Transl Med. 2019 Nov 27;11(520):
pubmed: 31776292
Science. 2014 Aug 1;345(6196):570-3
pubmed: 25011556
Curr HIV/AIDS Rep. 2020 Aug;17(4):343-353
pubmed: 32388691
J Virol. 2006 May;80(10):5074-7
pubmed: 16641299
Lancet HIV. 2018 May;5(5):e250-e258
pubmed: 29739699
PLoS Pathog. 2014 Mar 06;10(3):e1003958
pubmed: 24604066
PLoS One. 2017 Dec 29;12(12):e0190332
pubmed: 29287090
J Clin Invest. 2020 Apr 1;130(4):1699-1712
pubmed: 31910162
Clin Infect Dis. 2019 Nov 27;69(12):2236-2237
pubmed: 31063189
mBio. 2017 Aug 15;8(4):
pubmed: 28811349
J Infect Dis. 2008 Mar 1;197(5):714-20
pubmed: 18260759
Curr HIV/AIDS Rep. 2018 Oct;15(5):382-387
pubmed: 30159813
Eur J Immunol. 2001 Nov;31(11):3207-17
pubmed: 11745337

Auteurs

Veronica Obregon-Perko (V)

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.

Katherine M Bricker (KM)

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.

Gloria Mensah (G)

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.

Ferzan Uddin (F)

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.

Mithra R Kumar (MR)

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Emily J Fray (EJ)

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Robert F Siliciano (RF)

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Howard Hughes Medical Institute, Baltimore, Maryland, USA.

Nils Schoof (N)

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.

Anna Horner (A)

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.

Maud Mavigner (M)

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.

Shan Liang (S)

Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.

Thomas Vanderford (T)

Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.

Julian Sass (J)

Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.

Cliburn Chan (C)

Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.

Stella J Berendam (SJ)

Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.

Katharine J Bar (KJ)

Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

George M Shaw (GM)

Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Guido Silvestri (G)

Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.

Genevieve G Fouda (GG)

Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.

Sallie R Permar (SR)

Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.

Ann Chahroudi (A)

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA achahro@emory.edu.
Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta and Emory University, Atlanta, Georgia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH